Citius Pharmaceuticals Inc (CTXR)
0.665
-0.02
(-3.57%)
USD |
NASDAQ |
May 08, 16:00
0.69
+0.02
(+3.76%)
After-Hours: 20:00
Citius Pharmaceuticals Free Cash Flow (Quarterly): -6.135M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.135M |
| September 30, 2023 | -6.800M |
| June 30, 2023 | -9.583M |
| March 31, 2023 | -7.853M |
| December 31, 2022 | -4.824M |
| September 30, 2022 | -6.332M |
| June 30, 2022 | -7.712M |
| March 31, 2022 | -9.665M |
| December 31, 2021 | -4.652M |
| September 30, 2021 | -45.59M |
| June 30, 2021 | -4.830M |
| March 31, 2021 | -4.271M |
| December 31, 2020 | -9.565M |
| September 30, 2020 | -3.358M |
| June 30, 2020 | -3.993M |
| March 31, 2020 | -4.468M |
| December 31, 2019 | -5.114M |
| September 30, 2019 | -2.907M |
| June 30, 2019 | -3.522M |
| March 31, 2019 | -3.850M |
| December 31, 2018 | -2.158M |
| September 30, 2018 | -2.505M |
| June 30, 2018 | -2.246M |
| March 31, 2018 | -4.126M |
| December 31, 2017 | -2.441M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.429M |
| June 30, 2017 | -2.402M |
| March 31, 2017 | -0.8246M |
| December 31, 2016 | -1.315M |
| September 30, 2016 | -1.767M |
| June 30, 2016 | -2.562M |
| March 31, 2016 | -0.8745M |
| December 31, 2015 | -0.6971M |
| September 30, 2015 | -0.7053M |
| June 30, 2015 | -0.6284M |
| March 31, 2015 | -0.3169M |
| December 31, 2014 | -0.7348M |
| June 30, 2014 | -0.0485M |
| March 31, 2014 | -0.0325M |
| December 31, 2013 | -0.5219M |
| September 30, 2013 | -0.0074M |
| June 30, 2013 | -0.0032M |
| March 31, 2013 | -0.0097M |
| December 31, 2012 | -0.0002M |
| September 30, 2012 | -0.0054M |
| June 30, 2012 | -0.006M |
| March 31, 2012 | -0.0067M |
| December 31, 2011 | -0.0022M |
| September 30, 2011 | -0.0049M |
| June 30, 2011 | -0.0051M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-45.59M
Minimum
Sep 2021
-2.907M
Maximum
Sep 2019
-7.957M
Average
-5.114M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
| QuidelOrtho Corp | 31.80M |
| TransCode Therapeutics Inc | 10.13M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |